AMT-130 Breakthrough: 75% Slower Huntington's | AcademicJobs UK
NIHR-backed AMT-130 trial at UCL and Cardiff shows 75% slower Huntington's progression, marking a historic advance in gene therapy research.
clinical-trialsresearch-publication-newsuk-research

